ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,252Medicare Part D Prescriptions Filled, Including Refills

Rank: 368 out of 1499

$519K Total Retail Price of All Prescriptions

Rank: 322 out of 1499

420 Patients Receiving at Least One Drug in Part D
33%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 3,092 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LISINOPRIL 317 98 1 1
HYDROCODONE-ACETAMINOPHEN 311 84 S3 2 4
AMLODIPINE BESYLATE 226 70 3 6
SIMVASTATIN 218 83 4 3
OMEPRAZOLE 204 62 5 5
RANITIDINE HCL 187 55 6 15
TRAMADOL HCL 176 37 7 16
METFORMIN HCL 173 67 8 8
LEVOTHYROXINE SODIUM 154 85 9 2
FUROSEMIDE 130 32 10 7
POTASSIUM CHLORIDE 130 34 10 11
CITALOPRAM HBR 125 40 12 14
NEXIUM 125 44 12 28
GABAPENTIN 117 33 14 13
METOPROLOL TARTRATE 115 46 15 10
HYDROCHLOROTHIAZIDE 113 38 16 9
TRAZODONE HCL 113 21 16 32
CYCLOBENZAPRINE HCL 108 15 R 18 41
PROAIR HFA 106 19 19 30
CYMBALTA 104 0 20 40
LANTUS 101 47 21 46
HYDROXYZINE PAMOATE 101 27 R 21 194
TRICOR 97 17 23 103
CARVEDILOL 88 42 24 22
LOVASTATIN 79 29 25 19
RISPERIDONE 79 34 25 74
COMBIVENT 79 32 25 78
ADVAIR DISKUS 75 13 28 37
SERTRALINE HCL 73 25 29 24
CLONIDINE HCL 72 39 30 57
ATORVASTATIN CALCIUM 70 19 31 17
BENZTROPINE MESYLATE 70 0 R 31 144
ATENOLOL 69 29 33 21
DIVALPROEX SODIUM 67 14 34 100
METOPROLOL SUCCINATE 67 21 34 20
CLOPIDOGREL 66 35 36 39
QUETIAPINE FUMARATE 66 35 36 72
AZITHROMYCIN 66 25 36 45
IBUPROFEN 62 0 39 70
ROPINIROLE HCL 61 32 40 55
MELOXICAM 60 16 41 27
OLANZAPINE 60 13 41 140
HYDROXYZINE HCL 59 11 R 43 173
PRENATAL PLUS 59 13 43 157
NAPROXEN 59 16 43 63
LOVAZA 59 31 43 136
SPIRIVA 58 22 47 44
FLUTICASONE PROPIONATE 57 0 48 31
MIRTAZAPINE 55 28 49 50
ZETIA 54 0 50 91
PRAVASTATIN SODIUM 53 27 51 18
FLUOXETINE HCL 53 20 51 43
PLAVIX 52 31 53 54
HALOPERIDOL 52 0 53 172
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.